Rivera Christina G, Narayanan Prasanna P, Patel Robin, Estes Lynn L
Hospital Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA
Hospital Pharmacy Services, Mayo Clinic, Rochester, Minnesota, USA.
Antimicrob Agents Chemother. 2016 May 23;60(6):3854-5. doi: 10.1128/AAC.00442-16. Print 2016 Jun.
The CLSI cefepime breakpoints were revised to include a susceptible-dose-dependent (SDD) category for Enterobacteriaceae, with the intention that higher cefepime doses be used for these isolates. In this study, 1.6% of Enterobacteriaceae isolates were reported as SDD, with Escherichia coli the most common SDD organism. Cefepime was prescribed in three cases (4.8%); the majority of SDD isolates were treated with a carbapenem. Enterobacteriaceae with cefepime SDD MICs were not commonly treated with cefepime at our institution.
临床和实验室标准协会(CLSI)修订了头孢吡肟的折点,为肠杆菌科细菌增加了剂量依赖敏感(SDD)类别,目的是对这些分离株使用更高剂量的头孢吡肟。在本研究中,1.6%的肠杆菌科分离株报告为SDD,其中大肠埃希菌是最常见的SDD菌。有3例(4.8%)使用了头孢吡肟;大多数SDD分离株使用碳青霉烯类进行治疗。在我们机构,头孢吡肟SDD最低抑菌浓度(MIC)的肠杆菌科细菌通常不使用头孢吡肟治疗。